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Abstract: Vitamin A is a fundamental micronutrient that regulates various cellular patterns. Vitamin
A deficiency (VAT) is a worldwide problem and the primary cause of nocturnal blindness especially in
low income countries. Cystic fibrosis (CF) is a known risk factor of VAD because of liposoluble vitamin
malabsorption due to pancreatic insufficiency. We describe a case of a 9-year-old girl who experienced
recurrent episodes of nocturnal blindness due to profound VAD. This little girl is paradigmatic for
the explanation of the key role of the gut–liver axis in vitamin A metabolism. She presents with
meconium ileus at birth, requiring intestinal resection that led to a transient intestinal failure with
parenteral nutrition need. In addition, she suffered from cholestatic liver disease due to CF and
intestinal failure-associated liver disease. The interaction of pancreatic function, intestinal absorption
and liver storage is fundamental for the correct metabolism of vitamin A.
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1. Introduction
Humans, and in general higher animals, must obtain vitamin A from their diet, either as a
pre-formed vitamin (retinol) from meat, eggs and milk, or as pro-vitamin carotenoids, primarily found
in yellow fruit, vegetables and carrots [1].
These are both fat soluble molecules that need bile acid micelle solubilization to be digested. In
the lumen of the small intestine, long chain fatty acid retinol esters (the most represented pre-formed
vitamin in the diet) are hydrolyzed by pancreatic lipase and by enzymes on the brush border, and
therefore free retinol can be absorbed by enterocytes. Beta carotene, the most abundant of carotenoids
in the diet, does not require digestion to enter intestinal cells and diffuses through the cell membrane
via facilitated transport linked to a surface receptor. In the cell, retinol is esterified again to retinyl
ester (mainly with palmitate) and is embedded in chylomicrons together with beta carotene, other
carotenoids and dietary lipids to be secreted in lymphatic vessels. Chylomicrons undergo remodeling
processes resulting in chylomicron remnants, which are richer in retinyl esters and are up taken by the
liver; here, retinol can be stored or can be bound to serum retinol binding protein (RBP4), a protein of
hepatic origin, and delivered to peripheral tissues [2].
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Normally the liver contains a two-year store of vitamin A, mainly as retinyl palmitate and stearate
which can be hydrolyzed to retinol and secreted when needed [3].
Differently, carotenoids in the bloodstream are bound to high-density lipoprotein (HDL) and
low-density lipoprotein (LDL) with other lipids [1].
These micronutrient compounds are either individually or collectively required throughout life and
regulate many processes including cell differentiation, proliferation and development, embryogenesis,
growth, normal metabolism and immune function. Moreover, beta carotene also has an important
role as an antioxidant too. In retinal pigment epithelium retinol is efficiently up taken by a membrane
receptor, stimulated by retinoic acid 6 (STRA6), with high affinity for RBP4, and while bound to a
cellular RBP, is converted into 11-cis retinaldehyde, a chromophore that joins with the protein opsin to
form rhodopsin, the molecular complex involved in vision [4].
Vitamin A deficiency (VAD) can be defined as serum retinol concentration lower than 0.70 µmol/L
(less than 0.20 mg/L) [5] and is especially prevalent in low income countries [6], where malnutrition
frequently occurs. Nevertheless, hypovitaminosis A due to inadequate intake is the leading cause of
childhood blindness worldwide; while rare in developed countries [7], it can arise due to intestinal
lipid malabsorption, pancreatic insufficiency, liver and bowel disease or surgical shortening.
According to these premises, we describe the case of a 9-year-old girl with a neonatal diagnosis of
cystic fibrosis (CF) with cholestatic liver disease and a history of bowel surgical shortening presenting
with night blindness secondary to VAD.
Data were collected retrospectively and anonymized after parents’ approval with informed
consent signature. No ethical clearance was applicable according to national regulations.
2. Case Report
A full-term newborn girl developed abdominal distention with emesis and failure to pass
meconium 12 h after birth. The pregnancy had been complicated by an antenatal diagnosis of
polyhydramnios and dilated bowel loops. The mother was in good clinical condition without any
history of vitamin deficit before or during pregnancy.
The baby underwent an extensive enterectomy with small bowel resection (involving 30 cm of the
proximal ileum, the terminal atresic ileum, the ileocecal valve and the cecum) and ileostomy formation
on day one of life.
The diagnosis of CF was confirmed by DNA analysis, showing compound heterozygosity for
known disease-causing mutations (F508del/L1077del).
During the first months of life, the patient presented with abnormal liver enzyme levels with normal
total and direct bilirubin levels. Abdominal ultrasound revealed mild hepatomegaly and steatosis.
Despite a severe intestinal malabsorption with steatorrhea (steatocrit of about 20%), both weight
and height increased, and growth pattern was satisfactory.
Minimal enteral feeds were tolerated, and the baby was dependent on parenteral nutrition (PN)
including fat-soluble vitamin supplementation (A 1300 UI/die, D 240 UI, E 4.2 UI, K 120 µg per day).
According to CF nutritional guidelines [4], she received oral nutrition support and multivitamin
supplementation (including vitamin A at 4000 UI daily).
The patient remained under close clinical follow-up until six months of age, when she developed
a bowel obstruction due to adhesions, which required additional bowel surgery. After surgery, a total
length of 102 cm of small bowel was measured with a termino-terminal ileocolic anastomosis without
ileocecal valve.
For this condition of type 2 short bowel with intestinal failure, she was trained for home parenteral
nutrition and discharged. Home PN (HPN) was successfully administered for the next 15 months
when it was gradually stopped because of normal growth.
She was then regularly followed-up at the CF center with adequate oral dietary intake via
oral nutrition, pancreatic enzyme replacement therapy and liposoluble vitamin supplementation at
high dose.
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At four years of age, she started complaining of slow dark adaptation and nyctalopia. No other
symptoms were reported. An ophthalmic examination was performed: slit lamp examination
was remarkable for a Bitot’s spot without retinal dystrophy; electroretinography (ERG) was within
normal limits.
Night blindness due to systemic VAD was suspected and confirmed by a serum level of 0 mg/L
(normal range of 0.30–0.70 mg/L), measured by high performance liquid chromatography (HPLC).
Fasting hypoglycemia was also documented, suggesting impaired intestinal absorption; thus,
despite being within normal growth parameters, complementary HPN was restarted in order to
provide additional calories and micronutrients.
Within the first month of HPN, the night blindness resolved.
After 10 months of parenteral supplementation, despite treatment with ursodeoxycholic acid
and efforts to optimize enteral feeding and cycling of HPN, severe intrahepatic cholestasis developed
(Figure 1).
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Figure 1. Correlation between liver function tests (AST—ALT direct bilirubin), vitamin A levels,
parenteral nutrition (PN) ad inistration and vita in A supple entation.
Therefore, in consideration of her optimal clinical conditions and normal levels of micronutrients,
HPN was stopped again.
Two years after HPN interruption, despite normal growth and no clinical symptoms, the patient’s
ERG showed a significant decrease in scotopic responses in both eyes with a mild reduction in photopic
responses in the left eye (Figure 2).
Serum vitamin A level was below 0.11 mg/L, while serum levels of the other liposoluble vitamins
values were within normal range. Therefore, intramuscular vitamin A supplementation (100,000 UI
monthly) was started and maintained, as serum vitamin A had remained only at trace levels; however,
a prompt improvement in the ERG waveforms was observed.
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Figure 2. Patient’s full-field electroretinogram (ERG) (A) before vitamin A supplementation: decreased
scotopic responses in both eyes and depressed photopic response in the left eye; (B) after vitamin A
supplementation: normal.
3. Discussion
We describe for the first time the case of a child with short bowel syndrome associated with CF
suffering from recurrent night blindness.
The patient described here is paradigmatic as all main risk factors for VAD were present due to
an impaired gut–liver axis related to CF, meconium ileus which led to short bowel syndrome with
absence of the terminal ileum and ileocecal valve, pancreatic insufficiency and cholestatic liver disease
(Figure 3).
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Figure 3. Risk factors related to vitamin A deficiency. CF = cystic fibrosis; VAD = vitamin A deficiency.
Bitot’s spots in combination with nyctalopia should promptly suggest the presence of acquired
vitamin A deficiency.
First of all, vitamin A is necessary for the maintenance of the ocular surface, as it is involved
in epithelial cell growth, regeneration, conjunctival epithelial cell RNA and glycoprotein synthesis
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helping to maintain the conjunctival mucosa and corneal stroma. Secondly, in the retina, retinol acts
as the backbone of the photosensitive visual pigment in both rod and cone photoreceptors. The rod
system is much more sensitive to vitamin A deficiency than the cone system. Therefore, nyctalopia is
the most common and earliest symptom of vitamin A deficiency, whereas Bitot’s spot and conjunctival
and corneal xerosis tend to occur after long periods of deficiency [8].
Approximately 85–90% of patients with CF suffer from pancreatic insufficiency, which predisposes
them to a reduced enterohepatic circulation of bile acids leading to malabsorption of fat and fat-soluble
vitamins (A, D, E, K), and reduced levels of RBP, which is essential for transport of retinol from the
liver to tissues [9].
Night blindness in children with CF has been reported since the late 1980s [10]. Those reports
drove the interest in liposoluble vitamins with the publication of the largest prospective study on
children with CF reporting vitamin A deficiency in 29% of the studied population whereas vitamin E
and D deficiencies were detected in 22% and 25%, respectively [11].
More recently, the prevalence of vitamin A deficiency in adolescents with CF has been assessed.
A large retrospective study from Australia found an increasing prevalence from 10% in 2007 to 13%
in 2010 [12], while a more recent study on a Dutch pediatric population found a prevalence of only
2% [13]. However, those studies do not report any patients with clinical symptoms.
Night blindness has been also attributed to conditions of intestinal malabsorption, in particular
in patients who have undergone intestinal bypass or bariatric surgery (even a long time after
surgery) [14,15]. Regarding short bowel syndrome in particular, a prospective study on adults
demonstrated that subjects undergoing intestinal rehabilitation have a high risk of developing vitamin
A deficiency, especially after HPN weaning [16].
Furthermore, the residual intestine can undergo adaptation due to structural and functional
changes, leading to an increase in surface area and enhanced nutrient absorptive capacity. This adaptive
process is characterized by increased villus height and crypt depth as a result of cellular hyperplasia.
Several lines of evidence have implicated vitamin A as a potential modulator of intestinal mucosal
adaptive growth in rat models of massive small bowel resection. The speculative mechanism seems
to be via retinoid-responsive genes, which were shown to be upregulated in the adapting remnant
small intestine at early time points after resection [17,18]. In addition, the same group of researchers
demonstrated that VAD seems to inhibit intestinal adaptation after small bowel resection because of
crypt cell proliferation reduction, crypt cell apoptosis augmentation and a reduction in enterocyte
migration rates [19].
Finally, liver disease could also be a cause of bile acid deficiency and reduced micellar solubilization
fat malabsorption, or the inability to synthetize RBP which is needed for the transport of vitamin A [2].
Furthermore, VAD may also exacerbate cholestasis due to possible excessive intrahepatic bile duct
proliferation, which has a negative effect on the digestion of lipids [20]. Cholestatic liver disease in
our patient is probably multifactorial and mediated by the sum of CF related liver disease [21], which
could account for the precocity of liver damage, and the development of intestinal failure-associated
liver disease [22] (Figure 1).
Normal findings in the other lipid soluble vitamins (namely D, E, K) demonstrates once more the
peculiarity of vitamin A metabolism.
The intestinal absorption of lipid soluble vitamins has been studied in a cellular model and found
to be different for vitamin A in comparison with the other lipid soluble vitamins. This model also
demonstrated that vitamin A has a competitive absorption pathway with the other three lipid soluble
vitamins, which could partially explain the different values found in our patient [23].
Another mechanism for the other lipid soluble vitamins is probably related to the central role of
liver absorption and storage, which has been demonstrated to be impaired in patients with chronic
liver diseases [24].
In conclusion, this case report nicely illustrates the central issue of vitamin A deficiency and
the key factors leading to the “vicious cycle of vitamin A deficiency” [25]. Patients with conditions
Nutrients 2019, 11, 1876 6 of 7
impairing intestinal absorption associated with liver disease could be at risk of VAD development; thus,
it is essential to monitor serum vitamin A level. When these conditions are particularly severe, oral
supplementation could be insufficient, and the parenteral route of administration could be required.
Author Contributions: L.N., L.Z. conceptualized the paper and wrote the original draft; M.C. wrote the original
draft; A.B., L.C., A.M.C.B. curated the data; C.C. wrote, reviewed and edited the manuscript.
Funding: This research received no external funding.
Acknowledgments: Silvia Gabrielle Osnaghi for the oculist follow-up, Lauretta Valmarana for the dietetic
follow-up and Lorenzo D’Antiga, Director of the Pediatric Hepatology, Gastroenterology and Transplantation unit
of Bergamo.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Weber, D.; Grune, T. The contribution of β-carotene to vitamin A supply of humans. Mol. Nutr. Food Res.
2012, 56, 251–258. [CrossRef] [PubMed]
2. Blaner, W.S.; Li, Y.; Brun, P.-J.; Yuen, J.J.; Lee, S.-A.; Clugston, R.D. Vitamin A Absorption, Storage and
Mobilization. Subcell. Biochem. 2016, 81, 95–125. [PubMed]
3. Senoo, H.; Mezaki, Y.; Fujiwara, M. The stellate cell system (vitamin A-storing cell system). Anat. Sci. Int.
2017, 92, 387–455. [CrossRef] [PubMed]
4. Harrison, E.H. Mechanisms of Transport and Delivery of Vitamin A and Carotenoids to the Retinal Pigment
Epithelium. Mol. Nutr. Food Res. 2019, e1801046. [CrossRef] [PubMed]
5. Adeli, K.; Higgins, V.; Trajcevski, K.; White-Al Habeeb, N. The Canadian laboratory initiative on pediatric
reference intervals: A CALIPER white paper. Crit. Rev. Clin. Lab. Sci. 2017, 54, 358–413. [CrossRef]
[PubMed]
6. Song, P.; Wang, J.; Wei, W.; Chang, X.; Wang, M.; An, L. The Prevalence of Vitamin A Deficiency in Chinese
Children: A Systematic Review and Bayesian Meta-Analysis. Nutrients 2017, 9, 1285. [CrossRef] [PubMed]
7. Chiu, M.; Dillon, A.; Watson, S. Vitamin A deficiency and xerophthalmia in children of a developed country.
J. Paediatr. Child Health 2016, 52, 699–703. [CrossRef]
8. Fiore, P.; De Marco, R.; Sacco, O.; Priolo, E. Nightblindness, xerophthalmia, and severe loss of visual acuity
due to unnecessary dietary restriction. Nutrition 2004, 20, 477. [CrossRef]
9. Dodge, J.A.; Turck, D. Cystic fibrosis: Nutritional consequences and management. Best Pract. Res. Clin.
Gastroenterol. 2006, 20, 531–546. [CrossRef]
10. Rayner, R.J.; Tyrrell, J.C.; Hiller, E.J.; Marenah, C.; Neugebauer, M.A.; Vernon, S.A.; Brimlow, G. Night
blindness and conjunctival xerosis caused by vitamin A deficiency in patients with cystic fibrosis. Arch. Dis.
Child. 1989, 64, 1151–1156. [CrossRef]
11. Feranchak, A.P.; Sontag, M.K.; Wagener, J.S.; Hammond, K.B.; Accurso, F.J.; Sokol, R.J. Prospective, long-term
study of fat-soluble vitamin status in children with cystic fibrosis identified by newborn screen. J. Pediatr.
1999, 135, 601–610. [CrossRef]
12. Rana, M.; Wong-See, D.; Katz, T.; Gaskin, K.; Whitehead, B.; Jaffe, A.; Coakley, J.; Lochhead, A. Fat-soluble
vitamin deficiency in children and adolescents with cystic fibrosis. J. Clin. Pathol. 2014, 67, 605–608.
[CrossRef] [PubMed]
13. Woestenenk, J.W.; Broos, N.; Stellato, R.K.; Arets, H.G.M.; van der Ent, C.K.; Houwen, R.H.J. Vitamin A
intake and serum retinol levels in children and adolescents with cystic fibrosis. Clin. Nutr. 2016, 35, 654–659.
[CrossRef] [PubMed]
14. Spits, Y.; De Laey, J.-J.; Leroy, B.P. Rapid recovery of night blindness due to obesity surgery after vitamin A
repletion therapy. Br. J. Ophthalmol. 2004, 88, 583–585. [CrossRef] [PubMed]
15. Chae, T.; Foroozan, R. Vitamin A deficiency in patients with a remote history of intestinal surgery. Br. J.
Ophthalmol. 2006, 90, 955–956. [CrossRef] [PubMed]
16. Luo, M.; Estívariz, C.F.; Schleicher, R.L.; Bazargan, N.; Leader, L.M.; Galloway, J.R.; Ziegler, T.R. Prospective
analysis of serum carotenoids, vitamin A, and tocopherols in adults with short bowel syndrome undergoing
intestinal rehabilitation. Nutrition 2009, 25, 400–407. [CrossRef] [PubMed]
Nutrients 2019, 11, 1876 7 of 7
17. Swartz-Basile, D.A.; Rubin, D.C.; Levin, M.S. Vitamin A status modulates intestinal adaptation after partial
small bowel resection. JPEN J. Parenter. Enteral Nutr. 2000, 24, 81–88. [CrossRef] [PubMed]
18. Wang, L.; Tang, Y.; Rubin, D.C.; Levin, M.S. Chronically administered retinoic acid has trophic effects in the
rat small intestine and promotes adaptation in a resection model of short bowel syndrome. Am. J. Physiol.
Gastrointest. Liver Physiol. 2007, 292, G1559–G1569. [CrossRef]
19. Swartz-Basile, D.A.; Wang, L.; Tang, Y.; Pitt, H.A.; Rubin, D.C.; Levin, M.S. Vitamin A deficiency inhibits
intestinal adaptation by modulating apoptosis, proliferation, and enterocyte migration. Am. J. Physiol.
Gastrointest. Liver Physiol. 2003, 285, G424–G432. [CrossRef]
20. Weiss, B.; Barshack, I.; Onaca, N.; Goldberg, I.; Berkovich, Z.; Melzer, E.; Jonas, A.; Reifen, R. Vitamin A
deficiency associated with enhanced proliferation of bile duct epithelial cells in the rat. Isr. Med. Assoc. J.
IMAJ 2010, 12, 82–86.
21. Debray, D.; Narkewicz, M.R.; Bodewes, F.A.J.A.; Colombo, C.; Housset, C.; de Jonge, H.R.; Jonker, J.W.;
Kelly, D.A.; Ling, S.C.; Poynard, T.; et al. Cystic Fibrosis-related Liver Disease: Research Challenges and
Future Perspectives. J. Pediatr. Gastroenterol. Nutr. 2017, 65, 443–448. [CrossRef]
22. Norsa, L.; Nicastro, E.; Di Giorgio, A.; Lacaille, F.; D’Antiga, L. Prevention and Treatment of Intestinal
Failure-Associated Liver Disease in Children. Nutrients 2018, 10, 664. [CrossRef]
23. Goncalves, A.; Roi, S.; Nowicki, M.; Dhaussy, A.; Huertas, A.; Amiot, M.-J.; Reboul, E. Fat-soluble vitamin
intestinal absorption: Absorption sites in the intestine and interactions for absorption. Food Chem. 2015, 172,
155–160. [CrossRef]
24. Saeed, A.; Dullaart, R.P.F.; Schreuder, T.C.M.A.; Blokzijl, H.; Faber, K.N. Disturbed Vitamin A Metabolism in
Non-Alcoholic Fatty Liver Disease (NAFLD). Nutrients 2017, 10, 29. [CrossRef]
25. Wiseman, E.M.; Bar-El Dadon, S.; Reifen, R. The vicious cycle of vitamin a deficiency: A review. Crit. Rev.
Food Sci. Nutr. 2017, 57, 3703–3714. [CrossRef]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
